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I. PROJECT IDENTIFICATION 
 
A.   Programme/Project number (Please refer to the Guidelines) 
 
  B.   Programme title. Programme title should be filled for Prioritised & Strategic research proposal only and repeated in all application form 
for each project under the same programme. 
 
 
 
B1. Project title (For Experimental Applied, Prioritised and Strategic research proposal). 
Synthesis of 2-O-α-D-glucopyranosyl L-ascorbic acid by cyclomaltodextrin glucanotransferase from Bacillus sp. 
 
C.   Project leader (Please indicate the name as in NRIC of the project leader) 
       Name: Roshanida Binti A. Rahman 
 
       NRIC: 771023-08-6528 
 
  C1. Programme Head (Prioritised & Strategic research proposal is required to fill this section and should be repeated in all project under 
this programme) 
 
       Name: 
 
       NRIC: 
D.   Organisation (Please indicate the name, address, telephone and fax of the organisation in which the project leader is based)  
Department of Bioprocess Engineering 
Faculty of Chemical Engineering and Natural Resources Engineering 
Universiti Teknologi Malaysia 
81310 UTM Skudai 
JOHOR 
 
Tel : 07-5576160 ext 5491 
Fax : 07-5581463 
E-mail : r-anida@utm.my 
E. Key words (Please provide a maximum of 5 key words that describe the research of the project.  The key words will be incorporated 
in a database on Malaysian research)  
 
Cyclodextrin glucanotransferase, Enzyme purification, Enzyme characterisation, Synthesis of 2-O-α-D-
glucopyranosyl L-ascorbic acid. 
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II. OBJECTIVES OF THE PROJECT 
 
A. Specific objective of the project (Please describe the measurable general and specific objectives of the project and 
define the expected results.  Use results-oriented wording with verbs such as "to define ...", "to determine ...", "to identify ...") 
1. To synthesize 2-O-α-D-glucopyranosyl L-ascorbic acid (AA-2G) from ascorbic acid and glucose using CGTase 
enzyme 
2. To characterise suitable CGTase sources for the transglycolase reaction 
3. To determine the biochemical parameters required for AA-2G production  
B. Research background of the project (Please indicate if the project is new, modified or extended.  Give a summary   of your 
literature review to indicate the originality of the proposed research, and describe related research to assist in 
 assessing the research rationale and the potential for success) 
 • Project status (please indicate) X New  Modification to  Extension of 
     previous project  Existing project 
        
 • Literature review summary 
 
The transglycosylation to synthesis AA-2G (2-O-α-D-glucopyranosyl L-ascorbic acid) has been studied using 
commercially available enzymes for efficient mass production. Among various enzymes from microorganisms 
and plants, rice seed α-glucosidase and CGTase (cyclodextrin glucanotransferase) are able to form AA-2G 
(Aga et al. 1991, Tanaka et al. 1991). AA-2G is considered to be superior to other chemically-synthesised L-
ascorbic acid derivatives in terms of the reaction specificity and efficiency in large-scale production. AA-2G is 
bioavailable as an ascorbate source for in vivo and in vitro (Komano et al. 1998). The enzymatic production of 
AA-2G is more applicable than chemical synthesis of other AA derivatives such as L-ascorbic acid 2-phosphate 
(AA-2P), L-ascorbic acid 2-methylether (AA-2M) in terms of reaction steps, regiospecificity and production costs 
(Mima et al. 1970). However, the conventional methods using rice seed α-glucosidase continue to have some 
problems in the purification of enzymes from these sources and a low yield of AA-2G. It is easier to purify 
CGTase from bacteria than α-glucosidase from rice. CGTase is stable at high temperature. Therefore, the 
enzymatic transglycosylation at high temperature using CGTase is suitable for the mass production of AA-2G. 
Although many studies are currently carried out on the biochemical properties, nutritional value and clinical 
effects of AA-2G, AA-2G is still not produced industrially. This is due to the lack of research related to the safety 
of the human body and the method for efficient mass production. In this study, we would like to utilize local 
enzyme CGTase for the production of L-ascorbic acid. Biochemical, kinetic and reaction process data or 
experiment are needed to explore this new biotransformation process.  
 
 
References 
1. Aga H., Yoneyama M., Sakai S., Yamamoto I. (1991). Synthesis of 2-O-α-D-glucopyranosyl L-ascorbic acid 
by cyclomaltodextrin glucanotransferase from Bacillus stearothermophilus. Agric. Biol. Chem. 55: 1751-
1756. 
2. Komano Y., Sakamoto T., Egawa M., Tanaka M., Yamamoto I. (1998). Enhancing effect 2-O-α-D-
glucopyranosyl L-ascorbic acid, a stable ascorbic acid derivatives, on collagen synthesis. Biol. Pharm. Bull. 
21:662-666.   
3. Mima H., Nomura H., Imai Y., Takashima H. (1970). Chemistry and application of ascorbic acid phosphate. 
Vitamin. 41: 387-398. 
4. Tanaka M., Muto N., Yamamoto I. (1991). Characterization of Bacillus stearothermophilus cyclodextrin 
glucanotransferase in ascorbic acid 2-O-α-glucosidase formation. Biochim. Biophys. Acta. 1078: 127-132. 
 
• Related research 
 
Optimisation of cyclodextrin gluconaotransferase production using sago starch as carbon source. (VOT 74034) 
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C. Type of research (Please indicate the type of research, one only; see definition of terms in the Guidelines) 
   1. Scientific research (fundamental research) 
    
 X  2. Technology development (applied research) 
    
   3. Product/process development (design end engineering) 
    
   4. Social/policy research 
    
D. Socio-economic objective being addressed by the project (Please identify the Sector, SEO Category and SEO 
Group which most appropriately describe the main beneficiary of your proposed project.  For definitions, please refer to the Guidelines.  
Refer to the R&D Priority Areas for RMK8 document attached, and the Malaysian R&D Classification System brochure for the SEO 
Group code) 
 
• Sector  : Science and Engineering (09) 
 
• SEO Category : S50100 Natural Sciences, Technologies and Engineering 
 
• SEO Group and Code : S50106 Applied Sciences and Technologies     
 E. Target Area, Research Theme, Programme being addressed (Please identify the Target Area, Research 
Theme and Programme under which your proposed project falls.  Refer to the attached R&D Priority Areas for 
RMK8.  For definitions please refer to the Guidelines) 
• Target Area : Biology 
 
• Research Theme : Microbiology 
 
•   Research Theme Code :  EA 50405 
 
• Programme : Development of novel compounds from microbes 
 
F. Fields of research (Please identify the two main FOR Categories, FOR Groups and FOR areas, which most appropriately describe 
the scientific discipline of your proposed project.  For definitions, please refer to the Guidelines.  Refer to the third revision of Malaysian 
R&D Classification System brochure for the FOR classification and codes) 
• Primary Field of Research 
  
- FOR Category : Biological Sciences 
 
 - FOR Group and Code : F10808 Biotechnology 
 
- FOR Area : Biotransformation 
 
• Secondary Field of Research 
 
 - FOR Category : Biological Sciences 
 
- FOR Group and Code : F10801 Biochemistry 
-  
- FOR Area : Proteins 
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III. BENEFITS OF THE PROJECT 
A. Direct customers/beneficiaries of the project (Please identify clearly the potential customers/beneficiaries of the research 
results and provide details of their relevance, eg, size, economic contribution, etc) 
Industries: 
• Pharmaceutical Industries : AA-2G (2-O-α-D-glucopyranosyl L-ascorbic) from CGTase is more applicable 
than chemical synthesis of other AA derivatives. 
• Nutraceutical industries : AA-2G appplication as Vitamine C supplement 
  
Research institute :  
• Exchange of technical expertise, idea and information 
 
 
B. Outputs expected from the project (Please refer to the list of outputs in the Guidelines and give further details)  
a)   AA-2G as both nutraceutical and pharmaceutical derivative. 
b)   Purified CGTase as transglycolase enzyme.  
c)   Development of a commercially viable process of producing nutraceutical & pharamaceutical derivatives from simple product such as ascorbic    
      acid and dextrins, owing to the establishment of more efficient enzymatic bioconversion process. 
d)   Establishment of viable bioconversion process in producing higher  value product using enzyme from local bacterial strains. 
e)   Expertise development in fermentation technology, microbial technology, enzyme technology and enzyme/product purification process. 
 
 
C. Technology transfer/diffusion approach (Please describe how the outputs of the project will be transferred to the direct 
beneficiaries/customers.  Please also state if the project outputs are sustainable, ie, if they can be utilised without further external 
assistance) 
a) The outputs of this project can be disseminated via: 
• Seminars, Publications in journals and Patent(s)  
 
b) For beneficiaries: 
• Design of commercially viable enzymatic bioconversion process of producing AA-2G from ascorbic acid and dextrins 
• Design of bioprocess technology in producing purified enzyme CGTase  
• Availability of AA-2G for the application in nutraceutical and pharmaceuticals industries 
 
c) The sale of licensing / patent rights or technological know-how to the beneficiaries 
D. Organisational outcomes expected (Please refer to the list of outcomes in the Guidelines and give further details)  
 
• The possibilities of having postgraduate students doing Msc. and Ph.D degree. 
• Development of research unit which has expertise in reaction and synthesis of AA-2G from CGTase as 
L-ascorbic acid derivative. 
• Improvement of laboratory facilities with new equipment. 
• The organisations will benefit from the payment of technology fees and royalties from the 
commercialisation of the completed process of manufacturing. 
 
 
E. Sector/national impacts expected  (Please refer to the list of impacts in the Guidelines and give further details)  
 
• Linkages with related industries and companies especially pharmaceutical industry. 
• Linkages between local and international research organisation.  
• Development of a new higher value-added products from cheaper raw materials.  
• Collaboration between domestic research institutions and universities on IRPA project. From this 
collaboration, a wide range of products application can be identified and be expanded. 
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IV. PROJECT STRUCTURE 
A. Research organisations involved in the project (Please identify all research organisations collaborating in the project, and 
describe their role/contribution to the project) 
 
 
1. Universiti Teknologi Malaysia (Department of Bioprocess Engineering, FKKKSA) 
 
• Enzyme purification 
• Enzyme characterisation 
• Study AA-2G synthesis parameters 
 
2. Universiti Kebangsaan Malaysia (School of Bioscience and Biotechnology) 
 
• Reactor studies for AA-2G production 
• Biochemical parameters optimisation in reactor 
 
3. SIRIM BERHAD (Bioprocess and Chemical Technology Centre) 
 
• Enzymatic reaction mechanism for optimization production of AA-2G 
• Biochemical parameters optimisation – kinetic modeling  
 
 
B. Industry linkages (Please identify any industry or end-user group involved in the project, and describe its role/contribution to the 
project) 
Lingkages with local pharmaceutical company to develop vitamin C by using L-ascorbic acid derivative synthesis from 
local enzyme CGTase will be developed 
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C. Project Team 
 
Name1 Organisation Man-month2 on 
project 
Project Leader (Please provide name) 
Roshanida Binti A. Rahman 
 
 
UTM 
 
 
3x3 = 9 
Programme Head (Please provide name) 
 
 
  
Researchers (Please provide names or numbers of researchers) 
Dr Rosli Md Illias  
Dr Firdausi Razali 
Professor Madya Dr Osman Hassan 
Kamarulzaman Kamaruddin 
Dr. Neelam Shahab 
 
 
UTM 
UTM 
UKM 
SIRIM 
SIRIM 
 
 
2x3=6 
2x3=6 
1x3=3 
1x3=3 
1x3=3 
Support Staff (Please indicate how many) 
 
1 Lab assistant 
 
 
 
 
                         - 
 
 
 
 
1x3=3 
Contract Staff (Please indicate how many) 
 
1 Research Assistant 
 
 
 
 
 
UTM 
 
 
 
 
 
12x3 = 36 
 
 
    
  Total 69 
(for 3 years) 
 
 
   1. Please attach the curriculum vitae of key research personnel.  Please follow the format included in Appendix A. 
   2. Based on 24 man-days per month; please use the man-days per staff category included in the Staff Cost Estimation Form in Appendix D. 
 
 
 
V. RESEARCH APPROACH 
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A. Research methodology (Please describe the research methodology to be followed. Identify specialised equipment, facilities 
and infrastructure which are required for the project, and indicate which are new) 
Bacillus species has been isolated from local and preliminary characterisation of the crude enzyme was found to 
produce cyclodextrin glucanotransferase (CGTase). Therefore, we are interested to purify and further characterise 
the enzyme to synthesis AA-2G. The following are the strategies to be adopted. 
 
1. Purification of CGTase 
Affinity chromatography method has been chosen in order to purify the CGTase enzyme. In this method, the 
extracellular crude enzyme will be mixed with potato starch and ammonium sulphate. After centrifugation, the starch 
bound CGTase will be washed twice with distilled water. Adsorbed CGTase will be eluted by shaking with 500 ml of 1 
mM β-cyclodextrin for 30 min and centrifuged. The supernatant fluid containing the crude CGTase will be further 
purified using affinity column prepared using β-cyclodextrin-derivatived sepharose 4B based on the modified 
divinylsulphone method by Parath and Ersson 1973. 
 
2. Assay of the CGTase activity  
CGTase will be assayed according to the method established by Kaneko (1987). A reaction mixture containing 1 ml 
of 2% (w/v) starch in 50 mM sodium phosphate buffer (pH 6.0) and appropiate amount of enzyme solution will be 
stopped by adding 3.5 ml of 30 mM NaOH solution, then 0.5 ml of 0.02% (w/v) phenolphthalein in 50 mM Na2CO3 
solution. After incubation for 15 min at room temperature, the % decrease at A550 will be measured. 
 
3. Protein estimation 
Protein estimation will be carried out using the standard method by Lowry. 
 
4. Characterisation of enzyme for AA-2G synthesis 
The purified CGTase will be characterised to get the biochemical information about the enzyme and performance in 
producing AA-2G. The effect of pH, temperature and metal ion (CoCl2, MgSO4, ZnSO4, FeSO4, etc) on CGTase 
activity, stability, kinetic analysis and substrate screening for AA-2G synthesis will also be carried out. Determination 
of the molecular weight of the enzyme will be done by SDS-PAGE. 
 
5. Assay for AA-2G production 
The standard reaction mixture contained sodium ascorbate, dextrin or other saccharides and CGTase from Bacillus 
species. The reaction mixture was incubated at 37°C for 24 h (pH 6.5). To hydrolyse AA-2-oligosaccharides 
produced by CGTase, glucoamylase (20 unit) was added to the reaction mixture and incubated at 55°C, pH 4.5 for 
24 h. The determination of AA-2G content was carried out by HPLC with µBondapak C18 (3.9 x 300 mm). The assay 
conditions were as follows: detection at 238 nm; mobile phase was 0.1 M KH2PO4 / 0.1 M H3PO4 (pH 2) at 0.5 ml min-
1. The amount of AA-2G was calculated on the basis of the peak area. 
 
6. Assay for glucose-releasing  
Glucose-releasing activity was determined by measuring the rate of glucose release from α-cyclodextrin or other 
saccharides. The reaction mixture consisted of 1% α-cyclodextrin or other saccharides in a 0.1 M sodium citrate 
buffer (pH 6.5) and 2500 units / CGTase ml, and was incubated at 37°C for 2 h. The determination of glucose 
content was carried out by HPLC with Waters Sugar-pak I (6.5 x 300 mm). The assay conditions were as follows: 
mobile phase was acetonitrile / water (65:35, v/v) at 1 ml min-1. The amount of glucose was calculated on the basis of 
its standard curve of the peak area. 
 
7. Optimisation of parameter for synthesis AA-2G 
Response surface method will be used to optimise parameters of AA-2G synthesis from CGTase. Design Expert 
software will be used to get the model and optimum condition for the parameters. 
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B. Project activities (Please list and describe the main project activities, including those associated with the transfer of the research 
results to customers/beneficiaries.  The timing and duration of research activities are to be shown in the Gantt chart in Form VI) 
Project Activities 
 
1. Collection of the literature review related to the study (CRITICAL REVIEW) 
 
2. Enzyme purification 
- Growth of the microorganism in the medium culture 
- Preparation of buffer, affinity chromatography and column set up 
- Purification process using Affinity chromatography 
 
3. Enzyme characterisation for AA-2G synthesis 
- Effect of pH and temperature on enzyme activity and stability 
- Effect of metal ion and chemical reagents such as EDTA, MgCl2, FeSO4, MgCl2, ZnSO4 etc on enzyme activity, 
kinetics analysis and substrate screening 
- Molecular weight determination using SDS-PAGE and pI determination 
 
4. Enzymatic bioconversion of AA-2G  
- Biochemical parameters optimisation for AA-2G production 
- Reaction mechanism and kinetics optimisation 
- HPLC/TLC analysis 
- The RSM (Response Surface Method) application 
 
5. Small scale batch reactor Optimisation 
- Bioreactor parameters optimisation for AA-2G production 
- Reactor/ Scale up kinetics  
- HPLC/TLC analysis 
- The RSM (Response Surface Method) application 
 
6. Report writing and publication 
  
 
 
Enzyme purification 
Enzymatic bioconversion of AA-2G 
Small scale batch reactor optimisation 
Enzyme characterisation for AA-2G synthesis 
Critical review 
Report writing and publication 
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C. Key milestones (Please list and describe the principal milestones of the project.  The timing of milestones is to be shown in the Gantt 
chart on Form VI.  A key milestone is reached when a significant phase in the project is concluded, e.g. completion of 
test, review, commissioning of equipment, etc) 
1. Purified enzyme 
2. Enzyme characterisation for AA-2G synthesis 
3. Enzymatic Bionversion of AA-2G  
4. Small scale batch reactor Optimisation of AA-2G synthesis 
D. Risks of the project (Please describe the factors that may cause delays in, or prevent implementation of, the project as     proposed 
above; estimate the degree of risk) 
 
 • Factors: 
1. Equipment failure  
2. Delayed delivery of items on purchase 
 
 
 Low Medium High 
 • Technical risk:   X    
        
 • Timing risk:   X    
        
 • Budget risk:   X    
        
E. Duration (State the planned starting date of the project and the elapsed time, in months, to complete this project; technology transfer 
activities should be excluded from elapsed time) 
• Starting date    January 2003 
 
 
• Duration/elapsed time   36 months 
VI. PROJECT SCHEDULE 
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 2003 2004 2005 2006 2007
Project Activities                          J F M A M J J A S O N D J F M A M J J A S O N D S1 S2 S1 S2 S1 S2
 
1. Critical Review 
 
2. Enzyme purification 
Purification process using Affinity
chromatography. 
 
                           
   
 
   
   
• 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Enzyme characterisation 
Effect of pH, temperature and metal ion on
enzyme activity. 
Molecular weight determination. 
 
                            
 
 
• 
 
 
 
 
  
 
    
 
 
 
 
 
 
 
4. Enzymatic bioconversion of  
AA-2G 
Biochemical parameters optimization. 
Reaction mechanism and kinetics 
optimization. 
HPLC/TLC analysis. 
RSM (Response Surface Method) 
application. 
 
 
                        
 
 
 
 
• 
 
 
 
    
   
 
 
 
 
 
 
 
 
 
     
    
5. Reactor Optimization of AA-2G 
Bioreactor parameters optimization.  
Reactor/ Scale up kinetics.  
HPLC/TLC analysis. 
RSM (Response Surface Method)
application. 
 
                            
 
 
 
 
• 
 
 
 
 
 
 
 
        6. Technology Transfer Activities and    
        Publication 
                              
           Seminar, Conference and Meeting                                     
 
• Planned milestone  
S1: First Semester   
S2: Second Semester 
       
           VII.     PROJECT COSTS  
 
A. Staff costs (Please include the yearly staff costs of the project.  For computation, use the Staff Cost Estimation Form in Appendix D.  Numbers in parentheses refer to expense codes) 
 Staff Category Year 1 (2003.)    Year2 (2004.) Year 3 (2005.) Year 4 (……….) Year 5 (……….) Total  
 • Salaried personnel   (11100) 
• Temporary and contract personnel  (J 400) 
73598 
20000 
73598 
20000 
73598 
20000 
   220794
60000 
 
 Sub-total staff costs 93598 93598 93598   280794  
       
B. Direct project expenses (Please include the yearly direct expenses of the project.  For computation, use the Direct Expenses Estimation Form in Appendix E.  Numbers in parentheses refer to expense codes) 
 Expense Category Year 1 (2003.)    Year2 (2004.) Year 3 (2005) Year 4 (……….) Year5 (……….) Total  
 • Travel and transportation (J 500) 
• Rentals (J 600) 
• Research materials and supplies (J 700) 
• Minor modifications and repairs (J 800) 
•        Special services (J 900) 
•   Special equipment and accessories (J 1000) 
2000 
 
 
40000 
4000 
4000 
 
30000 
3000 
 
 
30000 
4000 
3000 
3000 
 
 
22000 
2000 
3000 
   8000
 
 
92000 
10000 
10000 
 
30000 
 
 
 Sub-total direct expenses 80000 40000 30000   150,000  
       
C. Total cost (Please add the sub-totals of A and B) 
  Year 1 (2003.)    Year2 (2004) Year 3 (2005) Year 4 (……….) Year 5 (……….) Total  
  173598       133598 123598 430794
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VIII. PROJECT FUNDING 
 
A. Funding sources (Please indicate funding sources for the project; see list of funding sources in the Guidelines)                                                                                  
 Funding Sources RM % of Total Funding  
 
 
 
 
- IRPA Grant 
 
- Internal Funds 
 
- Other Sources (please specify) 
 
 
 
 
 
210000 
 
220794 
 
 
48.75 
 
51.25 
 
 Total 430794   100%
     
B. Disbursement schedule for IRPA funds, by participating research organization (Please indicate how IRPA funding for the project will be allocated)    
      Organisation Year 1
(2003.)    
Year2 
(2004.) 
Year 3  
(2005) 
Year 4 
 (……….) 
Year 5 
(……….) 
Total
  UTM
 
SIRIM 
 
UKM 
 
55000 
 
30000 
 
15000 
30000 
 
20000 
 
10000 
 
30000 
 
15000 
 
5000 
   115000
 
65000 
 
30000 
 
 Total IRPA Grant 100000 60000 50000   210000  
       
 A
J
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IX. CONTRACTUAL MATTERS 
 
A. Contractual obligations under this project (Please indicate any contractual obligations with third parties that will be entered in   
for this project) 
A confidentiality agreement between all researchers involved in this collaboration project in order to protect any 
technical data generated from this project 
 
B. Ownership of intellectual property rights (Please indicate the organisation(s) that will own the intellectual property rights that 
may arise from this project) 
 
 
 
Ownership of intellectual property rights will be negotiated on the basis of percentage involvement of each 
organisations i.e. UTM, UKM and SIRIM on this IRPA collaboration project. 
 
 
 
 
 
 
 
 
 
 
 
 
C. Approving Officer (of the organisation in which the Project Leader is based) 
 
 Name :     
       
Designation :      
       
Date :   Signature :  
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APPENDIX A - CURRICULUM VITAE 
 
Please follow the following format when submitting the curriculum vitae of key research personnel 
A. Personal Data 
1. Name :  ROSHANIDA BINTI A RAHMAN 
2. IC No :  771023-08-6528 
3. Date and Place of Birth :  23.10.77 / PERAK 
4. Sex :  FEMALE 
5. Nationality :  MALAYSIAN 
6. Name of Current Employer :  UTM 
7. Address 
 
:  DEPARTMENT OF BIOPROCESS ENGINEERING 
FACULTY OF CHEMICAL ENGINEERING AND NATURAL 
RESOURCES ENGINEERING 
UTM, SKUDAI, JOHOR 
8. Telephone No 
 
:  07-5576160 – EXT 5491 
9. Fax No 
 
:  07-5581463 
10. Title of Position Held 
 
:  LECTURER 
11. Signature of Researcher :   
 
12. 
 
Date 
 
: 
  
08.07.2002 
     
B. Educational Qualifications                                                                                                                                        
1. Academic Qualification 
 
Degree 
 
Field 
 
Year 
 
Name and Place of Institution 
 
(Repeat as necessary) 
 
Degree 
 
Field 
 
Year 
 
Name and Place of Institution 
 
 
: 
 
: 
 
: 
 
: 
 
 
  
 
Master of engineering 
 
Bioprocess engineering 
 
2002 
 
Universiti Teknologi Malaysia, Skudai, Johor 
  
 
 
B (sc) 
 
Chemical engineering (Bioprocess) 
 
1999 
 
Universiti Teknologi Malaysia, Skudai, Johor 
 
 
 2. Other Professional Courses 
Completed 
 
Field 
 
Year 
 
(Repeat as necessary) 
 
 
 
 
: 
 
: 
 
: 
 
  
 
 
• Short course on Response Surface Methodology: 30 
Jun – 1 July 2001 
 
• Workshop on Bioreactor Operation: 25 – 28 Mac 2002 
 
1 Number of Years of Experience 
in the Field Related to the 
Proposed Project 
 
:  3 years 
2 Fields of Specialisation 
 
:  Enzyme Technology 
3. Major Research 
Programmes/Projects 
Completed 
 
 
Title 
 
 
 
From 
 
To 
 
Position held 
 
Major output 
 
 
 
 
 
 
 
 
: 
 
 
 
: 
 
: 
 
: 
 
: 
 
 
  
 
 
 
 
Production of cyclodextrin glucanotransferase from Bacillus 
stearothermophilus HR1: partial characterisation and media 
optimisation 
 
1999  
 
2002 
 
Msc. Researcher 
 
Awarded M. Sc 
Thermostable CGTase enzyme 
3 papers in Local Conference 
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D. 
1. 
Research Achievements 
Honors and Awards 
:   
 
2. 
 
Major Publications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
: 
  
1. Roshanida Abd. Rahman, Rosli Md. Illias, Ghazali Mohd 
Nawawi, Siti Zalita Abd Talib, Wan Mokhtar Wan Yusoff, Aidil 
Abd Hamid, Kamarulzaman Kamaruddin. (2000). Production 
of thermostable cyclodextrin glucanotransferase from Bacillus 
stearothermophilus HR1. 12th National Biotechnology 
Seminar. 325-327. 
 
2. Roshanida A. Rahman, Rosli Md. Illias, Osman Hassan, 
Kamarulzaman Kamaruddin. (2001). Effect of nitrogen, 
phosphorus and mineral sources on the production of 
cyclodextrin glucanotransferase from Bacillus 
stearothermophilus HR1. 13th Biotechnology Seminar. 200-
204. 
 
    3.  Roshanida A. Rahman, Rosli Md. Illias, Mohd. Ghazali Mohd 
Nawawi, Osman Hassan, Kamarulzaman Kamaruddin. 
(2002). Optimisation of medium formulation for the production 
of cyclodextrin glucanotransferase (CGTase) from Bacillus 
stearothermophilus HR1. 12th Malaysian Society for Molecular 
Biology and Biotechnology Scientific meeting. 115.   
       
 4.  Rosli Md. Illias, Tien Siew Fen, Roshanida A. Rahman, Noor   
      Aini Adbul Rashid, Wan Mokhtar Wan Yusoff, Aidil Abd 
Hamid,   
      Osman Hassan, Kamarulzaman Kamaruddin. (2002).    
      Application of factorial design to study the effects of  
      temperature, initial pH and agitation on the production of  
      cyclodextrin glucanotransferase from Bacillus sp. G1.  
      Accepted for publication in ScienceAsia. 
 
5.  Roshanida A. Rahman, Rosli Md Illias, Mohd Ghazali Mohd  
     Nawawi, Ahmad Fauzi Ismail, Osman Hassan, Kamarulzaman  
     Kamaruddin. (2002). Optimization of growth medium for the  
     production cyclodextrin glucanotransferase from Bacillus  
    stearothermophilus HR1 using Design of Experiments..    
    Submitted for publication in Journal of Microbiology and   
    Biotechnology.  
 
 
3. Number of Patents :   
4. Major Commercial 
Achievements 
:   
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APPENDIX B - SUMMARY OF RELEVANT PAST RESEARCH PROJECT 
 
 
A. Project title 
Production of cyclodextrin glucanotransferase from Bacillus stearothermophilus HR1: partial characterisation and 
media optimisation. 
1. Relevance to proposed project 
Knowledege and experience of dealing with cyclodextrin glucanotransferase, enzyme assay, enzyme characterisation 
and optimisation. 
2. Organisation(s) that were involved in the project (Please indicate the organisation that led the project) 
Universiti Teknologi Malaysia 
D. Names of senior staff  
• Programme head: Dr. Rosli Md Illias 
• Project leader: Dr. Rosli Md Illias 
• Key researchers: Roshanida Binti A Rahman 
  
E. Description of the project (Please indicate project customers/beneficiaries, research approach adopted and outputs) 
 
   1. Production of thermostable cyclodextrin glucanotransferase from local strain of Bacillus stearothermophilus. 
 
   2. Sago starch which is a local source, was found to be the best effect of carbon source on the production of 
CGTase. 
 
   3. Production of CGTase was optimised by using response surface method.  
 
 
 
 
 
 
 
APPENDIX C - STAFF COST ESTIMATION WORKSHEET 
 
Role in Project Total Project Leader Researchers Support Staff Contract Staff 
Daily Rate (RM)  300 300 66.6 69.44 
Research Activities Man-Days1 
 
1. Literature survey 
 
2. Enzyme purification 
 
3. Enzyme characterisation 
 
 
73 
 
263 
 
216 
 
10 
 
32 
 
30 
 
23 
 
93 
 
52 
 
- 
 
15 
 
9 
 
40 
 
123 
 
125 
Total Year 1 (2003) Man-days 552 72 168 24 288 
Total Year 1 (2003) Cost (RM)2 93598 21,600 50,400 1,598 20,000 
  (11100) (11100) (11100) (J 400) 
 
1. Biochemical parameter  
 
2. Reaction mechanism and kinetic 
/ HPLC analysis 
 
3. Response Surface Method 
 
101 
 
375 
 
76 
 
16 
 
23 
 
33 
 
37 
 
107 
 
24 
 
 
6 
 
14 
 
4 
 
42 
 
231 
 
15 
 
Total Year 2 (2004 ) Man-days 552 72 168 24 288 
Total Year 2 (2004 ) Cost (RM)2 93598 21,600 50,400 1,598 20,000 
  (11100) (11100) (11100) (J 400) 
 
  1. Optimisation of AA-2G synthesis    
      parameter 
    
  2. Scale up kinetic parameter 
 
  3. Response Surface Method 
 
393 
 
 
95 
 
64 
 
 
32 
 
 
20 
 
20 
 
109 
 
 
35 
 
24 
 
 
19 
 
 
- 
 
5 
 
233 
 
 
40 
 
15 
Total Year 3 (2005 ) Man-days 552 72 168 24 288 
Total Year 3 (2005 ) Cost (RM)2 93598 21,600 50,400 1,598 20,000 
  (11100) (11100) (11100) (J 400) 
      
Total Year 4 (200_) Man-days      
Total Year 4 (200_) Cost (RM)2      
  (11100) (11100) (11100) (J 400) 
      
Total Year 5 (200_) Man-days      
Total Year 5 (200_) Cost (RM)2      
  (11100) (11100) (11100) (J 400) 
Total Project Man-days 1656 216 504 72 864 
Total Project Staff Cost (RM) 280794 64,800 151,200 4,794 60,000 
  (11100) (11100) (11100) (J 400) 
Total Man-months3 69 9 21 3 36 
Notes 
1. For each research activity, estimate the man-days required by each staff category. 
2. Compute the staff cost for each year by multiplying the total man-day by the daily rate of the corresponding staff category.  For daily rate  
              computation, refer to the Guidelines. 
3. Compute the total man-months required for the project by dividing the total project man-days by 24. 
Numbers in parentheses are expense codes as shown in Form VI 
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 Expense Categories and Items Year 1  
(2003)    
Year2  
(2004.) 
Year 3  
(2005.) 
Year 4 
(……..) 
Year 5 
(……..) 
Travel and transportation (J 500) 2000 3000 3000   
1. Visit sites and collect samples 
2. Attending seminars, workshop 
and meeting 
 
 
 
1000 
1000 
 
1000 
2000 
 
500 
2500 
 
  
Rentals (J 600)      
      
Research materials and supplies (J 700) 40000 30000 22000   
1. Chemicals and reagents (eg. Medium, 
enzymes) 
2. Glassware and gases (tips, eppendorf 
tube, cuvet) 
3. Consumable items 
20000 
 
5000 
15000 
15000 
 
5000 
10000 
10000 
 
2000 
10000 
  
Minor modifications and repairs (J 800) 4000 4000 2000   
1.  Maitenance and repair of HPLC and 
Chromatography 
2. Development of lab-scale for optimisation 
4000 3000 
 
1000 
1000 
 
1000 
  
Special services  (J 900) 4000 3000 3000   
1. HPLC analysis 
2. Reactor Fabrication 
2500 
1500 
 
1000 
2000 
1000 
2000 
  
Special equipment, accessories (J 1000) 30000     
1. Column for HPLC  
2. Incubator 
5000 
25000 
 
 
 
 
 
 
 
 
 
 
  
Total direct expenses 80000 40000 30000   
* If major equipment, please provide description on page 2 of this appendix 
Numbers in parentheses are expense codes as shown in Form VII 
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Special Equipment and Accessories  (Please describe and provide justification for major purchases) 
1. Description 
            HPLC columns  (µ Bondapak C18) 
 
 
2. Justification 
            Essential for ascorbic acid and AA-2G analyses to determine the AA-2G content. 
 
 
3. Estimated Cost 
            RM 5,000 
 
Special Equipment and Accessories (Please describe and provide justification for major purchases) 
1. Description 
          Incubator 
 
2. Justification 
           Incubation of microbes for purification, characterisation, protein estimation, CGTase assay, AA-2G assay and  
           optimisation of AA-2G synthesis parameter.  
 
3. Estimated Cost 
           RM25,000 
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